White Plains, NY, United States of America

Garen Manvelian

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Garen Manvelian in the Treatment of Sepsis and Hyperlipidemia

Introduction

Garen Manvelian is an accomplished inventor based in White Plains, NY, recognized for his significant contributions to the medical field. With a total of three patents, his work primarily focuses on addressing critical health conditions such as sepsis and hyperlipidemia. His innovative approaches are geared towards improving patient outcomes and providing more effective treatment options.

Latest Patents

Garen Manvelian's latest patents encompass groundbreaking methodologies in the medical industry. One notable patent involves the treatment of sepsis through the use of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Low Density Lipoprotein Receptor (LDLR) modulators. This patent describes methods to treat subjects suffering from sepsis, SIRS, septic shock, and/or MODS. It also outlines processes for identifying individuals at risk of developing these conditions as well as techniques for detecting PCSK9 and LDLR variant nucleic acid molecules.

Another important patent focuses on reducing or eliminating the need for lipoprotein apheresis in patients with hyperlipidemia. This invention provides methods that involve administering a PCSK9 inhibitor, such as an anti-PCSK9 antibody, to patients currently dependent on lipoprotein apheresis therapy. These methods aim to offer a more accessible treatment solution for managing hyperlipidemia and related conditions.

Career Highlights

Garen Manvelian is associated with Regeneron Pharmaceuticals, Inc., a prominent company at the forefront of biopharmaceutical innovation. His work at Regeneron has allowed him to translate scientific research into practical applications that can directly benefit patients dealing with severe health issues.

Collaborations

Throughout his career, Garen has collaborated with esteemed colleagues, including Robert C. Pordy and Julie Horowitz. These partnerships reflect the spirit of teamwork and innovation that drives the development of new therapeutic strategies in the biomedical sector.

Conclusion

Garen Manvelian's innovative contributions to the fields of medicine and pharmaceuticals illustrate his commitment to improving healthcare. Through his patents and collaborative efforts, he continues to pave the way for advanced treatment options that address some of the most pressing health challenges today. His work not only exemplifies the spirit of innovation but also highlights the vital role that inventors play in transforming scientific ideas into life-saving therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…